Live Breaking News & Updates on Adjuvant Treatment With Pembrolizumab

Stay updated with breaking news from Adjuvant treatment with pembrolizumab. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Adjuvant Pembrolizumab Provides Sustained DFS Benefit in Resected Stage IB, II, or IIIA NSCLC

Adjuvant treatment with pembrolizumab continued to induce a disease-free survival benefit vs placebo in patients with resected early-stage NSCLC, according to findings from the phase 3 PEARLS/KEYNOTE-091 trial. ....

United States , France General , Benjamin Besse , Institut Gustave Roussy , Christabel Wilson , Merck Sharp Dohme , Genzyme Corporation , Oncology Congress , Merck Co Inc , Gustave Roussy Cancer Center , Paris Saclay University , Eastern Europe , Western Europe , Taiho Oncology , Turning Point , Merck Sharp , Blue Bell , Phase 3 Pearls Keynote 091 Trial , Adjuvant Treatment With Pembrolizumab , Disease Free Survival , Patients With Resected Early Stage Nsclc ,